Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1975 1
1979 1
1980 3
1981 1
1982 2
1983 2
1984 1
1985 1
1986 2
1987 1
1988 3
1990 4
1991 1
1992 5
1993 6
1994 7
1995 1
1996 4
1997 9
1998 7
1999 5
2000 6
2001 9
2002 12
2003 11
2004 17
2005 13
2006 5
2007 10
2008 14
2009 8
2010 13
2011 14
2012 12
2013 16
2014 18
2015 4
2016 10
2017 16
2018 13
2019 14
2020 14
2021 7
2022 5
2023 7
2024 6

Text availability

Article attribute

Article type

Publication date

Search Results

310 results

Results by year

Filters applied: . Clear all
Page 1
Enucleation.
Moshfeghi DM, Moshfeghi AA, Finger PT. Moshfeghi DM, et al. Surv Ophthalmol. 2000 Jan-Feb;44(4):277-301. doi: 10.1016/s0039-6257(99)00112-5. Surv Ophthalmol. 2000. PMID: 10667436 Free article. Review.
In this review, the authors discuss choices, techniques, complications, and patient consent and follow-up before, during, and after enucleation. Controversies and results of the Controlled Ocular Melanoma Study are summarized....
In this review, the authors discuss choices, techniques, complications, and patient consent and follow-up before, during, and after enucleat …
Pembrolizumab versus ipilimumab for advanced melanoma: final overall survival results of a multicentre, randomised, open-label phase 3 study (KEYNOTE-006).
Schachter J, Ribas A, Long GV, Arance A, Grob JJ, Mortier L, Daud A, Carlino MS, McNeil C, Lotem M, Larkin J, Lorigan P, Neyns B, Blank C, Petrella TM, Hamid O, Zhou H, Ebbinghaus S, Ibrahim N, Robert C. Schachter J, et al. Lancet. 2017 Oct 21;390(10105):1853-1862. doi: 10.1016/S0140-6736(17)31601-X. Epub 2017 Aug 16. Lancet. 2017. PMID: 28822576 Clinical Trial.
Treatment assignments used blocked randomisation within strata. Eligible patients were at least 18 years old, with an Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1, at least one measurable lesion per Response Evaluation Criteria In Solid Tumors ver …
Treatment assignments used blocked randomisation within strata. Eligible patients were at least 18 years old, with an Eastern Coopera …
Uveal melanoma.
Spagnolo F, Caltabiano G, Queirolo P. Spagnolo F, et al. Cancer Treat Rev. 2012 Aug;38(5):549-53. doi: 10.1016/j.ctrv.2012.01.002. Epub 2012 Jan 24. Cancer Treat Rev. 2012. PMID: 22270078 Review.
Finally, ipilimumab, which targets the immune compartment, was reported to increase overall survival in cutaneous melanoma patients, with preliminary evidence of similar activity in ocular melanoma....
Finally, ipilimumab, which targets the immune compartment, was reported to increase overall survival in cutaneous melanoma patients, with pr …
Sorafenib in melanoma.
Mangana J, Levesque MP, Karpova MB, Dummer R. Mangana J, et al. Expert Opin Investig Drugs. 2012 Apr;21(4):557-68. doi: 10.1517/13543784.2012.665872. Epub 2012 Mar 7. Expert Opin Investig Drugs. 2012. PMID: 22394203 Review.
Additionally, clinical trial databases were examined to identify and summarize ongoing trials of sorafenib in melanoma patients. ...Furthermore, other less frequent subtypes such as mucosal or ocular melanoma still constitute promising targets; academi …
Additionally, clinical trial databases were examined to identify and summarize ongoing trials of sorafenib in melanoma patient …
Ultraviolet light and ocular diseases.
Yam JC, Kwok AK. Yam JC, et al. Int Ophthalmol. 2014 Apr;34(2):383-400. doi: 10.1007/s10792-013-9791-x. Epub 2013 May 31. Int Ophthalmol. 2014. PMID: 23722672 Review.
However, the evidence of the association between UV exposure and development of pinguecula, nuclear and posterior subcapsular cataract, ocular surface squamous neoplasia (OSSN), and ocular melanoma remained limited. There is insufficient evidence to determine whethe …
However, the evidence of the association between UV exposure and development of pinguecula, nuclear and posterior subcapsular cataract, ocul …
Clinical features and prognosis of patients with metastatic ocular and orbital melanoma: A bi-institutional study.
Liu X, Yue H, Jiang S, Kong L, Xu Y, Chen Y, Wang C, Wang Y, Zhu X, Kong Y, Zhang X, Qian J, Luo Z. Liu X, et al. Cancer Med. 2023 Aug;12(15):16163-16172. doi: 10.1002/cam4.6273. Epub 2023 Jul 6. Cancer Med. 2023. PMID: 37409486 Free PMC article.
PURPOSE: Metastatic ocular and orbital melanomas are extremely rare. The clinical characteristics and standard treatments for these patients are not fully established. ...Patient with CM had a high incidence of BRAF mutation, and the treatment of BRAF and MEK inhibitors co …
PURPOSE: Metastatic ocular and orbital melanomas are extremely rare. The clinical characteristics and standard treatments for these p …
Genetic prognostication in uveal melanoma.
Dogrusöz M, Jager MJ. Dogrusöz M, et al. Acta Ophthalmol. 2018 Jun;96(4):331-347. doi: 10.1111/aos.13580. Epub 2017 Nov 4. Acta Ophthalmol. 2018. PMID: 29105334 Free article. Review.
Non-random chromosome aberrations such as monosomy 3 and gain of chromosome 8q are strongly correlated with metastatic risk, while gain of chromosome 6p indicates a low risk. ...In this article, we review genetic prognostic indicators in UM, also comparing available geneti …
Non-random chromosome aberrations such as monosomy 3 and gain of chromosome 8q are strongly correlated with metastatic risk, while ga …
Biology of advanced uveal melanoma and next steps for clinical therapeutics.
Luke JJ, Triozzi PL, McKenna KC, Van Meir EG, Gershenwald JE, Bastian BC, Gutkind JS, Bowcock AM, Streicher HZ, Patel PM, Sato T, Sossman JA, Sznol M, Welch J, Thurin M, Selig S, Flaherty KT, Carvajal RD. Luke JJ, et al. Pigment Cell Melanoma Res. 2015 Mar;28(2):135-47. doi: 10.1111/pcmr.12304. Epub 2014 Sep 1. Pigment Cell Melanoma Res. 2015. PMID: 25113308 Free PMC article. Review.
Here, as a joint effort between the Melanoma Research Foundation's ocular melanoma initiative, CURE OM and the National Cancer Institute, the current understanding of the molecular and immunobiology of uveal melanoma is reviewed, and on-going laboratory research int …
Here, as a joint effort between the Melanoma Research Foundation's ocular melanoma initiative, CURE OM and the National Cancer …
310 results